Weaver Consulting Group Zoetis Inc. Transaction History

Weaver Consulting Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$157.07 - $174.35 $19,319 - $21,445	-123 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$137.1 - $165.37 $10,145 - $12,237	74 Added 151.02%	123 $20,000
Q2 2020 Jul 24, 2020	BUY	$111.92 - $142.53 $1,231 - $1,567	11 Added 28.95%	49 $7,000
Q1 2019 Jun 19, 2019	BUY	$81.56 - $100.67 $3,099 - $3,825	38 New	38 $4,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

Stay updated on Weaver Consulting Group with notifications on news.